<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>634</ReferenceId>
        <DateLastUpdated>2020-09-11-07:00</DateLastUpdated>
        <Article>
            <PubmedId>1749770</PubmedId>
            <Abstract>Crystal structures of the Fabs from an autoantibody (BV04-01) with specificity for single-stranded DNA have been determined in the presence and absence of a trinucleotide of deoxythymidylic acid, d(pT)3. Formation of the ligand-protein complex was accompanied by small adjustments in the orientations of the variable (VL and VH) domains. In addition, there were local conformational changes in the first hypervariable loop of the light chain and the third hypervariable loop of the heavy chain, which together with the domain shifts led to an improvement in the complementarity of nucleotide and Fab. The sugar-phosphate chain adopted an extended and "open" conformation, with the base, sugar, and phosphate components available for interactions with the protein. Nucleotide 1 (5'-end) was associated exclusively with the heavy chain, nucleotide 2 was shared by both heavy and light chains, and nucleotide 3 was bound by the light chain. The orientation of phosphate 1 was stabilized by hydrogen bonds with serine H52a and asparagine H53. Phosphate 2 formed an ion pair with arginine H52, but no other charge-charge interactions were observed. Insertion of the side chain of histidine L27d between nucleotides 2 and 3 resulted in a bend in the sugar-phosphate chain. The most dominant contacts with the protein involved the central thymine base, which was immobilized by cooperative stacking and hydrogen bonding interactions. This base was intercalated between a tryptophan ring (no. H100a) from the heavy chain and a tyrosine ring (no. L32) from the light chain. The resulting orientation of thymine was favorable for the simultaneous formation of two hydrogen bonds with the backbone carbonyl oxygen and the side chain hydroxyl group of serine L91 (the thymine atoms were the hydrogen on nitrogen 3 and keto oxygen 4).</Abstract>
            <ArticleYear>1991</ArticleYear>
            <ArticlePages>159-75</ArticlePages>
            <ArticleTitle>An autoantibody to single-stranded DNA: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Herron</LastName>
                    <ForeName>J N</ForeName>
                </Author>
                <Author>
                    <LastName>He</LastName>
                    <ForeName>X M</ForeName>
                </Author>
                <Author>
                    <LastName>Ballard</LastName>
                    <ForeName>D W</ForeName>
                </Author>
                <Author>
                    <LastName>Blier</LastName>
                    <ForeName>P R</ForeName>
                </Author>
                <Author>
                    <LastName>Pace</LastName>
                    <ForeName>P E</ForeName>
                </Author>
                <Author>
                    <LastName>Bothwell</LastName>
                    <ForeName>A L</ForeName>
                </Author>
                <Author>
                    <LastName>Voss</LastName>
                    <ForeName>E W</ForeName>
                    <Suffix>Jr</Suffix>
                </Author>
                <Author>
                    <LastName>Edmundson</LastName>
                    <ForeName>A B</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Pharmaceutics, University of Utah, Salt Lake City 84108.</Affiliations>
            <ArticleChemicalList>Autoantibodies;DNA, Single-Stranded;Immunoglobulin Fab Fragments;Immunoglobulin Heavy Chains;Immunoglobulin Light Chains;Immunoglobulin Variable Region;Oligonucleotides</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Autoantibodies(chemistry); Binding Sites, Antibody; Crystallography; DNA, Single-Stranded(chemistry); Immunoglobulin Fab Fragments(chemistry); Immunoglobulin Heavy Chains(chemistry); Immunoglobulin Light Chains(chemistry); Immunoglobulin Variable Region(chemistry); Lupus Erythematosus, Systemic(immunology); Mice; Models, Molecular; Molecular Sequence Data; Oligonucleotides(chemistry); Protein Conformation</ArticleMeshHeadingsList>
            <Journal>
                <Volume>11</Volume>
                <Issue>3</Issue>
                <Title>Proteins</Title>
                <Issn>1097-0134</Issn>
                <MedlineTa>Proteins</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>trinucleotide of deoxythymidylic acid d(pT)3</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Other Non-Sequence</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:74952</ChEBIId>
                        </Molecule>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I and PDB 1CBV</LocationOfData>
                <EpitopeId>189520</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables I, II, III, IV, V, Figures 2, 3, 4, 5, 6, 7 and PDB 1CBV</LocationOfData>
                        <BCellId>1985862</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10001405</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:9074</DiseaseState>
                                <DiseaseStage>Unknown</DiseaseStage>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the cited reference: Ballard et al. (1985) J Biol Chem 259: 3492-3498  [PMID: 6706969]. NZB/NZW F1 splenic lymphocytes were fused with the SP2/0-Ag 14 myeloma cell line. NZB/NZW F1 mice develop lupus.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.66</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The crystal structure of the BV04-01 Fab in complex with the epitope was solved by molecular replacement.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>BV04-01</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2b</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>BV04-01</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1CBV_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1CBV_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:74952</ChEBIId>
                                        </Molecule>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1CBV</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>D</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Conformational changes were observed in L1 and H3 CDRs in the bound Fab, comparing it with unbound Fab [PDB: 1NBV].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>D: ( DT)1, ( DT)2, ( DT)3</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>D: ( DT)1, ( DT)2, ( DT)3</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: T31, N32, A33, R52, S53, N56, D101, Q102, T103, G104, T105, A106, W107; L: H31, S32, Y37, H39, S96, T97, H98, V99</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>643.5</ContactAreaForAntigen>
                                <ContactAreaForAntibody>463.7</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

